IMMUNOCLIN CORP |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
James Munro
DFI | Director of Finance/CFO | 55 | 13-12-12 |
| Chief Tech/Sci/R&D Officer | - | 14-02-28 | |
Chad S. Johnson
COO | Chief Operating Officer | 55 | 13-12-12 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chad S. Johnson
COO | Chief Operating Officer | 55 | 13-12-12 |
| Chief Tech/Sci/R&D Officer | - | 14-02-28 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 28,831,154 | 26,831,154 ( 93.06 %) | 0 | 93.06 % |
Company contact information
Immunoclin Corp.
1420 North Street Suite 102
20005, Washington
+202-838-8141
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +50.70% | 791B | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B |
- Stock Market
- Equities
- Stock
- Company ImmunoClin Corp
